Brivlera

-  As adjunctive therapy in the treatment of patients with partial-onset seizures (POS) who have had an inadequate response or have significant intolerance to at least 2 other less costly anticonvulsant therapies (prior or current use); AND

-  Patients are not receiving concurrent therapy with levetiracetam; AND

-  Patients are under the care of a physician experienced in the treatment of epilepsy.

Note: Less costly anticonvulsant therapies may include the following: 

Phenytoin, carbamazepine, gabapentin, lamotrigine, vigabatrin, topiramate, etc.